Observational study / 2019
Mushroom consumption was not associated with the risk of total or most site-specific cancers in two large U.S. cohorts.
This prospective study followed 68,327 women and 44,664 men for up to 26 years, documenting 22,469 incident cancer cases. In pooled multivariable analysis, participants consuming five or more servings of mushrooms per week had no significantly different risk of total cancer compared to those who almost never consumed mushrooms (HR, 1.06; 95% CI, 0.98-1.14). Mushroom consumption was not associated with 16 site-specific cancers, although a marginal positive association was observed for lung cancer (P trend = 0.05).
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 68,327 women (Nurses' Health Study) and 44,664 men (Health Professionals Follow-up Study) free of cancer at baseline
- What was measured
- Risk of total and 17 site-specific incident cancers
THE PAPER
Mushroom Consumption and Risk of Total and Site-Specific Cancer in Two Large U.S. Prospective Cohorts.
Lee DH, Yang M, Keum N, Giovannucci EL, Sun Q, Chavarro JE. Cancer Prev Res (Phila), 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.